Professional Documents
Culture Documents
Chapter 1 - Nursing Process & Drug Therapy
Chapter 1 - Nursing Process & Drug Therapy
Drug Names
● Chemical Name
o Describes the drugs chemical composition and molecular structure
● Generic Name (Non-Proprietary name)
o Name given by the United States Adopted Name Council (All drugs have a
generic name, even when they are new; Main focus of this course!!)
● Trade Name (Proprietary Name)
o The drug name has a registered trademark; Use of the name is restricted by the
drugs patent owner (which is usually the manufacturer)
Pharmacology Principle
● Pharmaceutics
● Pharmacokinetics
● Pharmacodynamics
● Pharmacotherapeutics
● Pharmacognosy
Pharmaceutics
● Definition: The study of how various drug forms influence pharmacokinetic and
pharmacodynamic activities (Which basically means the dosage form design and how it
impacts the dissolution of a drug)
Pharmacokinetics
● Definition: The study of what the body does to the drug
o Absorption
o Distribution “THINK ADME”
o Metabolism
o Excretion (Or Elimination)
1
PHARMACOLOGY NOTES
Pharmacodynamics
● Definition: The study of what the drug does to the body
o The mechanism of drug actions in living tissues
2
PHARMACOLOGY NOTES
▪ (Acidic drugs like acidic environments; basic drugs like basic
environments)
o Solution of GI motility
▪ (Keeping it in the stomach too long and taking it longer for the drug to get
to the intestines)
Routes
● A drugs route of administration affects the rate and extent of absorption of that drug
o Enteral (GI Tract)
o Parenteral (**FASTEST** EX: IVs)
o Topical
Enteral Route
● The drug is absorbed into the systemic circulation through the oral or gastric mucosa (In
the stomach lining) of the small intestine
o Oral
o Sublingual FASTEST ABSORPTION
o Buccal
o Rectal
First-Pass: Effect
● The metabolism of a drug and its passage from the liver into the circulation
o A drug given via the oral route may be extensively altered by the liver before
reaching the systemic circulation (high first-pass effect)
o The same drug given by IV bypasses the liver, preventing the first-pass effect
from taking place, and more drug reaches the circulation
▪ (But, when given by IV, it goes directly to the systemic circulation)
▪ (The first-pass effect means that you can get a medication orally but its
sent to the liver 1st and the rest of your body (systemic circulation) 2nd
▪ (Must be taken orally to have the effect)
▪ (Hepatic portal systems sends medication to the liver 1st)
Parenteral Route
● Intravenous (Fastest delivery to blood circulation)
● Intramuscular
● Subcutaneous
● Intradermal
● Intraarterial- artery (given here to go directly to certain organs)
● Intrathecal- spine
● Intraarticular- joint
Topical Route
● Skin (Including transdermal patches)
● Eyes
● Ears
● Nose
3
PHARMACOLOGY NOTES
● Lungs (Inhalation) 🡪 Inhalers
● Rectum (Can be external as well; you don’t completely bypass the first-pass effect; about
50/50)
● Vagina
Distribution
● The transport of a drug in the body by the bloodstream to its site of action
o Protein binding
▪ FATS want to go with fats; keeps it in the blood and allows for more drug
interactions
o Water soluble vs. fat (lipid) soluble
▪ Lipid (fat) soluble drugs penetrate membranes much easier because they
prefer to be in fat; Most are fat soluble to get through membranes faster
o Blood-brain barriers
▪ Defensive mechanisms; protect the CNS; SMALL lipid soluble compounds
can get through the barrier
o Areas of rapid distribution: heart, liver, kidneys, brain
▪ Drugs tend to go here FIRST
o Areas of slow distribution: Muscle, skin, fat
Metabolism/ Biotransformation
● Definition: The biochemical transformation of a drug into an inactive metabolite, a mere
soluble compound, or a more potent metabolite
o Liver
o Skeletal Muscle
o Kidneys
o Lungs
o Plasma
o Intestinal Mucosa
▪ The liver makes things more polar because they are easier to eliminate at
that point
▪ The metabolism makes the compound less lipid soluble and more polar so
it CANNOT be reabsorbed and is then ELIMINATED
● Biologic transformation of a drug into:
o An inactive metabolite
o A more soluble compound
▪ (A more potent metabolite)
● Factors that decrease metabolism
o Cardiovascular dysfunction
o Renal insufficiency
o Starvation
o Obstructive jaundice (Clogged bile duct)
o Slow acetylator (Conjugation reaction; There are also fast acetylators and it is
dependent on genetics whether they are fast or slow)
o Erythromycin or ketoconazole drug therapy
● Factors that increase metabolism
4
PHARMACOLOGY NOTES
o Fast acetylator (Genetically decided whether you’re fast or slow)
o Barbiturate therapy (Need a long half-life)
o Rifampin therapy (Increases enzymes; Need a long half life)
● Delaying drug metabolism causes
o Accumulation of drugs
o Prolonged action of the drugs 🡪 drug toxicity
● Stimulating drug metabolism causes
o Diminished pharmacologic effects
Excretion
● Definition: The elimination of drugs from the body
o Kidneys (Main Organ)
o Liver
o Bowel
▪ Biliary excretion
▪ Enterohepatic recirculation
Half-Life
● The time it takes for one half of the original amount of drug to be removed from the body
● A measure of the rate at which a drug is removed after about 5 half-lives
● Steady state
o The longer the half-life, the longer it will take you to get to the steady state
o Amount removed= amount absorbed; Use blood plasm serum; not always
accurate (Used to determine the concentration of the drug in your body)
Onset, Peak, and Duration
● Onset
o Definition: The time it takes for the drug to elicit a therapeutic response
● Peak
o Definition: The time it takes for a drug to reach its maximum therapeutic
response
● Duration
o Definition: The time a drug concentration is sufficient to elicit a therapeutic
response
Therapeutic Drug Monitoring
● Peak level: Highest blood level
● Trough level (nadir): lowest blood level
Pharmacodynamics: MoA
● Receptor interactions
● Enzyme interactions **General**
● Nonselective interactions
Pharmacotherapeutics: Typed of Therapies
5
PHARMACOLOGY NOTES
● Acute therapy (Short-term)
● Maintenance Therapy (Treats symptoms)
● Supplemental/ Replacement therapy (Insulin/Iron)
● Palliative Therapy (Try to make the patient comfortable)
● Supportive Therapy (EX: Fluids and electrolytes)
● Prophylactic Therapy (Preventative)
● Empiric Therapy (Based on an educated guess for treatment)
Contraindications
● Definition: Any characteristics of the patient, especially a disease state, that makes the
use of a given medication dangerous for the patient.
● It is important to assess for contraindications
o Doesn’t mean that the drug won’t work but it causes harm
Monitoring
● Therapeutic index
o Definition: Ratio of a drug’s toxic level to the level that provides therapeutic
benefits
▪ (Toxic dose/ effective dose)
● Tolerance
o Definition: Decreasing response to repeated drug doses
▪ Pain medications and opiods
● Dependence
o Definition: Physiologic or psychological need for a drug
● Interactions may occur with the other drugs or food
o A drug interaction is the alteration of a drug’s action by:
▪ Other prescribed drugs
▪ OTC Medications
▪ Herbal therapies
● Drug Interactions
o Additive
o Synergistic
o Potentiation
o Antagonistic
o Incompatibility
Drug Sources
● Four main sources for drugs
o Plants
o Animals
o Minerals
o Laboratory Synthesis
6
PHARMACOLOGY NOTES
Life Span Considerations
● Pregnancy
● Breastfeeding
● Neonatal
● Elderly
Pregnancy
● The 1st trimester is the period of the greatest danger for drug-induced developmental
defects
● Drugs cross the placenta by diffusion
● During the last trimester the greatest percentage of maternally absorbed drug gets to the
fetus
● FDA Pregnancy Safety Categories
Breastfeeding
● Breastfed infants are at risk for exposure to drugs consumed by the mother
● Consider the risk-to-benefit ratio
Neonatal & Pediatric Considerations: Pharmacokinetics
● Absorption
o Gastric PH less acidic
o Gastric emptying is slowed
o Intramuscular absorption faster & irregular
● Distribution
o The younger the person, the greater the % of total body water (TBW)
o Greatest TBW means fat content is lower
o Decreased level of protein binding
o Immature blood-brain barrier; more drugs enter the brain
● Metabolism
o Liver immature, does not produce enough microsomal enzymes
o Older children may have increased metabolism; requiring higher doses than
infants
● Excretion
o Kidney immaturity affects glomerular filtration rate and tubular secretion
o Decreased perfusion rate at the kidneys may reduce excretion of drugs
7
PHARMACOLOGY NOTES
● Body surface area method
o Using the west nomogram
● Body weight dosage calculations
o Using mg/kg
The Elderly
● Elderly: Older than 65
● Use of the OTC medications
● Increased incidence of chronic illnesses
● Polypharmacy
Physiologic Changes in Elderly Patients
● Cardiovascular
● Gastrointestinal
● Hepatic
● Renal
The Elderly: Pharmacokinetics
● Absorption
o Gastric pH less acidic
o Gastric emptying slowed
o Movement therapy GI tract slowed
o Blood flow to the GI tract reduced
o Use of laxatives may accelerate GI motility
● Distribution
o Lower total body water (TBW) percentages
o Increased fat content
o Decreased production of proteins by the liver, resulting in decreased protein
binding of drugs (and increased circulation of free drugs)
● Metabolism
o Aging liver produces fewer microsomal enzymes, affecting drug metabolism
o Reduced blood flow to the liver
● Excretion
o Decreased glomerular filtration rate
o Decreased number of intact nephrons
8
PHARMACOLOGY NOTES
Schedule Abuse Potential Medical Use
C-1 High None
C-II High Accepted
C-III Less than C-II Accepted
C-IV Less than C-III Accepted
C-V Less than C-IV Accepted
9
PHARMACOLOGY NOTES
Chapter 7 – OTC drugs, Herbal, & Dietary Supplements:
Criteria for OTC Status
● Indication for use:
o Consumer must easily be able to:
▪ Diagnose condition
▪ Monitor effectiveness
o Benefits of correct usage must outweigh the risk
● Safety Profile
o Drug should have
▪ Favorable adverse event profile
▪ Limited interaction with other drugs
▪ Low potential for abuse
▪ High therapeutic index
● Practicality for OTC use
o Drug should be
▪ Easy to use
▪ Easy to monitor
Conventional Medicines Derived From Plants
Medicine Plant
Atropine Atropos Belladonna
Capsaicin Capsicum Frutescence
Cocaine Erythroxylon Coca
Codeine Papaver Somniferum
Ipecac Cephaelis Ipecauariha
Quinine Cinehana Officinalis
Scopolamine Datura Fastuosa
Senna Cassia Acutifolia
Paclitaxel Taxis Brevifolia
Vincristine Catharanthus Roseus
10
PHARMACOLOGY NOTES
● Dietary Supplement & Health Education Act (DSHEA) of 1994
o Herbal products are considered “dietary supplements” & NOT drugs
o No proof of efficacy or safety required
o No standards for quality control
o May claim effect but cannot promise a specific cure
o Supplement manufacturer does not have to provide the FDA with evidence on
which it relies to substantiate for safety or effectiveness of a product before or
after it makes the products
o Other countries (UK, France, Canada, Germany) require manufacturers to meet
quality and safety standards
Commonly Used Herbal Products
● Aloe:
● Feverfew:
● Ginkgo:
● Goldenseal:
● Valerian:
● Kava:
● Echinacea:
● Garlic:
● Ginseng:
● Hawthorn:
● Saw Palmetto:
● Melatonin:
11
PHARMACOLOGY NOTES
● Medications that relieve pain without causing loss of consciousness
o “Painkillers”
o Opiods
o Acetaminophen
o NSAIDS
● Acute Pain
o Sudden in onset
o Usually subsides once treated
● Chronic Pain
o Persistent or reoccurring
o Lasting 3-6 months or longer
o Often difficult to treat
▪ WILL OFTEN LEAD TO TOLERANCE
Pain Transmission
12
PHARMACOLOGY NOTES
Opioid Analgesics
● Pain relievers that contain opium, derived from the opium poppy or chemically related to
opium
● Narcotics: Very strong pain relievers
Means Opioid
● Codeine Sulfate
● Propoxyphene HCl
● Oxycodone
● Meperidine HCl (Demerol) (Acute use because when metabolized, its toxic)
● Hydromorphone
Agonists
Agonists – Antagonists
13
PHARMACOLOGY NOTES
● Bind to a pain receptor
● Cause a weaker neurologic response than a full agonist
● ALSO CALLED PARTIAL-AGONIST or mixed agonist
o Good for a patient who used to be an opioid addict
o Bad for someone who is currently opioid dependent because they cause withdraw
Antagonist
Opioid Receptors
● Mu Primary
● Kappa Receptors
● Delta
● Sigma
● Epsilon
● Respiratory insufficiency
14
PHARMACOLOGY NOTES
● Elevated intracranial pressure (Increase in pCO2 which increases vasodilation that
causes intracranial pressure)
● Morbid obesity
● Sleep apnea
● Paralytic ileus
● A pattern of compulsive drug use characterized by a continued craving for opioid and the
need to use the opioid for effects OTHER THAN pain relief **ADDICTION**
Opiates
16
PHARMACOLOGY NOTES
Chapter 44 – Anti-inflammatory & Anti-gout Drugs:
NSAIDs
● Large and chemically diverse group of drugs with the following properties:
o Analgesic (pain)
o Anti-inflammatory
o Antipyretic (fever)
o Antirheumatic (arthritis)
NSAIDs: MoA
● Salicylates
● Acetic acid derivatives
● Cyclooxygenase-2 (COX-2) inhibitors
● Enolic acid derivatives
● Propionic acid derivatives
NSAIDs: Salicylates
● Indomethacin (Indocin) 🡪 Very potent; Given to infants whose hearts won’t close on their
own
● Ketorolac (Toradol)
17
PHARMACOLOGY NOTES
● Diflofenac Sodium (Voltaren)
● Sulindac (Clinoril)
● Tolmetin (Tolectin)
● Etodolac (Lodine)
● Celecoxib (Celebrex)
o First and only remaining COX-2 Inhibitor
o Indicated for osteoarthritis, rheumatoid arthritis, acute pain syndromes,
ankylosing spondylitis, and primary dysmenorrhea
▪ Less harsh on the body (specifically the GI tract); ulcers
▪ COX-1 DOES ITS OWN THING
● Piroxicam (Feidene)
● Meloxicam (Mobic) Non-selective COX Inhibitors
● Nabumetone (Relafen)
● Fenoprofen (Nalfron)
● Flurbiprofen (Ansaid)
● Ibuprofen (Motrin, Advil)
● Ketoprofen (Orudis KT)
● Naproxen (Naprosyn, Aleve)
● Oxaprozin (Daypro)
NSAIDs: Indications
18
PHARMACOLOGY NOTES
● Dysmenorrhea
● Fever
NSAIDs: Salicylates
● Salicylates (Aspirin)
o More potent effect on platelet aggregation
▪ Analgesic
▪ Antipyretic
▪ Anti-inflammatory
▪ Antithrombotic effect: Used in the treatment od MI and other
thromboembolic disorders
● Non-selective COX-Inhibitor
● Should NOT be used with kids who have a viral infection
● Oldest, most used, and hardest on the GI tract
● Gastrointestinal
o Dyspepsia, heartburn, epigastric distress, nausea
▪ GI bleeding*
▪ Mucosal lesions*
● Misoprostol (cylotec) can be used to reduce these dangerous
effects
● Promote mucus formation in the GI tract
● ULCERS****
● Renal
o Reductions in creatine clearance
o Acute tubular necrosis with renal failure
▪ Renal failure especially in the elderly
Antigout Drugs
19
PHARMACOLOGY NOTES
● Allopurinol (Zyloprim)
o Used to reduce production of uric acid
● Colchine 🡪 Used for acute attacks
o Reduces inflammatory response to the deposits of urate crystals in joint tissue
● Probenecid (Benemid), Sulfinparazone (Antorlane)
o Increases excretion of uric acid in the urine
o Decreases uric acid amount; prevent gout attack
Anesthesia
General Anesthetics
● Drugs that induce a state in which the CNS is altered to produce varying degrees of:
o Analgesia
o Depression of consciousness
o Skeletal muscle relaxation
o Reflex reduction
o VERY DANGEROUS AND BRINGS PEOPLE JUST ABOVE DEATH
● Inhaled anesthetics 🡪 Slow onset but easy to control
o Volatile liquids or gases that are vaporized/mixed in O2 and inhaled
● Parenteral anesthetics 🡪 Work very FAST
o Administered by IV!
Inhaled Anesthetics
● Inhaled gas
o Nitrous oxide 🡪 Very safe and not potent: AKA laughing gas; Used when you don’t
need to be completely knocked out
● Inhaled Volatile Liquids
o Desflurance
o Enflurance (Ethrane)
20
PHARMACOLOGY NOTES
o Halothane (Fluothane)
o Isoflurane (Forane)
o Methoxyflurane (Penthrane)
o Sevoflurane
Injectable Anesthetics
● Used:
o To induce or maintain general anesthesia
o To induce amnesia
o As an adjunct to inhalation- type anesthetics
▪ Makes it happen very quickly
● Etomidate (Amidate)
● Ketamine (Ketalar)
● Methohexital (Brevital)*
● Propofol (Diprivan)* 🡪 Quickly metabolized; Can be used for controllability
● Thiamylal (Surital)
● Thiopental (Pentothal)* 🡪 Thio= sulfur; sulfur is very lipid soluble
o *May also be used as adjunctive drugs at lower doses
Adjunct Drugs
● Sedative-hypnotics
o Barbiturates (pentobarbital, secobarbital)
o Benzodiazepines (diazepam, midazolin)
o Hydroxyzine 🡪 Antihistamine
o Promethazine 🡪 Prevent nausea
▪ All are apart of balanced anesthesia; used to lower the dosage of the
general anesthesia because its potent and this makes it safe.
● Neuromuscular blocking drugs (NMBDs)
o Depolarizing drugs (succinylcholine)
o Nondepolarizing drugs (pancuronium, d-tuboocurarine, vecurconium)
● Anticholinergics
o Atropine, glycopyrrolate, scopolamine
▪ Decrease secretions in the respiratory tract
21
PHARMACOLOGY NOTES
o Orderly & systemic reduction of sensory and motor CNS functions
o Progressive depression of cerebral & spinal cord functions
Indications
Adverse Effects
Moderate Sedation
Local Anesthetics
22
PHARMACOLOGY NOTES
o Applied directly to the skin or mucous membranes
o Creams, solutions, ointments, gels, ophthalmic drops, lozenges, and
suppositories
● Parenteral
o Injected parenterally or into the CNS by various spinal injection techniques
● Spinal or intraspinal
o Intrathecal
o Epidural
● Infiltration
● Nerve block
● Topical
Local Anesthetics
● Procaine (Novocain)
● Tetracaine (Pontocaine)
● Lidocaine (Xylocaine)
● Mepivacaine (Carbocaine) AMI LOCAL
● Bupivacaine ANESTHETICS
Indications
23
PHARMACOLOGY NOTES
● Infiltration anesthesia and epinephrine
o Some local anesthetics used for infiltration or nerve block are combined with
vasoconstrictors
▪ To prevent systemic absorption of anesthetic
▪ To help confine local anesthetic to injected area
▪ To reduce local blood loss during the procedure
▪ Epinephrine, phenylephrine, and norepinephrine
● They don’t want vasodilation because it PROMOTES absorption;
so they add a vasoconstrictor
● You don’t want a local anesthetic to be absorbed because it causes
TOXICITY
● Nerve block anesthesia
o Used for surgical, dental, and diagnostic procedures
o Also used for therapeutic management of pain
o The anesthetic drug is injected directly into or around the nerve trunks or nerve
ganglia that supply the area in pain to be numbed
Adverse Effects
● Usually limited
● Adverse effects result if:
o Inadvertent intravascular injection occurs
o Excessive dose or rate of injection is given
o Slow metabolic breakdown occurs
o Injection into highly vascular tissue occurs
o “Spinal headache”, treated with an epidural blood patch
24
PHARMACOLOGY NOTES
● Nondepolarizing drugs
o Short acting
o Intermediate acting
o Long acting
● Succinylcholine
o Works similarly to neurotransmitter acetylcholine (Ach), causing depolarization
o Metabolism is slower then Ach, so as long as succinylcholine is present,
repolarization CANNOT occur
o Result: Flaccid muscle paralysis
▪ Succinylcholine is metabolized much slower than Ach!!!!!!
● Short-acting
o Mivacurium (Mivacron)
● Intermediate acting
o Atracurium (Tracrium), vecuronoim (Norcuron)
o Rocuronium (Zemuron)
● Long-acting
o Pancuronium (Pavulon), doxacurium (Nuromax)
o D-tubocurarine
▪ Look for the “cur” in the word to know it’s an NMBD
Nondepolarizing NMBDs
NMBDs: Indications
25
PHARMACOLOGY NOTES
o Blocks respiration
NMBDs: Safety
NMBDs: Overdose
● Sedatives
o Drugs that have an inhibitory effect on the CNS to the degree that they reduce:
▪ Nervousness
▪ Excitability
▪ Inability without causing sleep
● At a higher dose it can cause sleep!!
● Hypnotics
o Causes sleep
o A sedative can become a hypnotic if it is given a large enough dose
● Sedative- hypnotics: Dose dependent
o At low doses, calm the CNS without inducing sleep
o At high doses, calm the CNS to the point of causing sleep
▪ Barbiturates
▪ Benzodiazepines
Sleep
26
PHARMACOLOGY NOTES
● Rapid eye movement (REM) sleep
● Non-rapid eye movement (non-REM) sleep
● Sleep stages
● REM rebound 🡪 With medication; Help you sleep but you only have non-REM sleep;
When off the medication your body goes into REM sleep and causes nightmares
Benzodiazepines: Classification
● Classified as either:
o Sedative-hypnotic
o Anxiolytic (medication that relieves anxiety)
● Long-Acting
o Estazolam (Prosom), Flurazepam (Dalmane), Lorazepam (Ativan)
▪ Anxiety, seizures, panic, sedation, sleep disorder, alcohol dependence
● Short-Acting
o Temazepam (Restoril), Alprazolam (Xanax), Triazolam (Halcion)
▪ Amnesia, insomnia
● Intermediate Acting
o Estazolam
Benzodiazepines: MoA
27
PHARMACOLOGY NOTES
Benzodiazepines: Drug Effects
Benzodiazepines: Indications
● Sedation
● Sleep induction 🡪 Done with a HIGH dose
● Skeletal muscle relaxation
● Anxiety relief
● Treatment of alcohol withdraw 🡪 Can be very serious; causes seizures which this class of
medication treats/prevents
● Agitation
● Depression 🡪 Anxiety driven
● Epilepsy
● Balanced anesthesia 🡪 Lower general anesthesia dose is needed
● Moderate/conscious sedation
● Somnolence
● Confusion
● Coma
● Diminished reflexes
● Do NOT cause hypotension and respiratory depression unless taken with other CNS
depressants
● Treatment symptomatic and supportive
o Flumazenil as an ANTIDOTE 🡪 Blocks benzodiazepine receptors
28
PHARMACOLOGY NOTES
● May cause visual disturbances
● Potential interactions with alcohol, barbiturates, and psychoactive drugs
● Contraindicated in liver disease and alcoholism
● Patient should not operate heavy machinery during use
● First introduced in 1903; were the standard drugs for insomnia & sedation
● Habit forming; LOW therapeutic index
● Only a handful commonly used today due in part to the safety and efficacy of
benzodiazepines
o Controlled substance
o Benzo’s are used more because they are SAFER!
Therapeutic Index
● Site of action
o Brainstem (reticular formation)
● By facilitating GABA, nerve impulses traveling in the cerebral cortex are inhibited
o Do NOT bind to benzo-receptors
Barbiturates: Indications
● Hypnotics 🡪 Sleep
● Sedatives 🡪 Relax
29
PHARMACOLOGY NOTES
● Anticonvulsants 🡪 Epilepsy & Seizures
● Anesthesia for surgical procedures
● Ultra-short-acting
o Anesthesia for short surgical procedures
● Short-acting
o Sedation/sleep induction and control of convulsive conditions
● Intermediate-acting
o Sedation/sleep induction and control of convulsive conditions
● Long-acting
o Sleep induction, epileptic seizure prophylaxis
● Ultrashort
o Methohexital
o Thiopental
● Short
o Phenobarbital
o Secobarbital
● Intermediate
o Butobarbital
● Long
o Phenobarbital
o Mephobarbital
30
PHARMACOLOGY NOTES
Barbiturates: Toxicity & Overdose
● Additive effects
o ETOH, antihistamines, benzodiazepines, opioids
● Metabolism inhibited by other drugs
o MAOIs will prolong effects of barbiturates
● Increased metabolism of other drugs
o Reduced anticoagulant response, leading to possible clot formation
Muscle Relaxants
31
PHARMACOLOGY NOTES
o Malignant hyperthermia 🡪 Massive Ca+ release
● ADHD
o Stimulate areas in the brain responsible for mental alertness and attentiveness
● Anorexiant
o Suppress appetite control center in the brain
● Analeptic
o Neonatal apnea, bronchopulmonary dysplasia, postanesthetic respiratory
depression
o NOT USED VERY OFTEN
32
PHARMACOLOGY NOTES
● Narcolepsy
o Increase mental alertness
● Migraine headaches
o Caffeine, co-administered with other drugs, used to treat headache
o Vascular headaches caused by vasodilation
Adverse Effects
CNS Stimulants
33
PHARMACOLOGY NOTES
▪ Doxapram (Dopram)
▪ Methylxanthines, such as aminophylline, theophylline, and caffeine
● Caffeine
o Found in:
▪ OTC drugs
▪ Combination prescription drugs
▪ Foods and beverages
o Use with caution in patients with a history of:
▪ Peptic ulcers
▪ Recent myocardial infarction (heart attack)
▪ Dysrhythmia
▪ Stimulates acid secretion
o Many Uses
▪ Neonatal apnea
▪ Respiratory depression in adults
▪ Enhances effects of analgesics and migraine medications
▪ Stimulates CNS (NoDoz, vivarin) 🡪 Will keep you awake
● Seizure
o Brief episode of abnormal electrical activity in nerve cells of the brain
● Convulsion
o Involuntary spasmodic contractions of any or all voluntary muscles throughout
the body, including skeletal and facial muscles
● Epilepsy
o Chronic, recurrent pattern of Seizures
● Primary (idiopathic)
o The cause cannot be determined
o More than 50% of epilepsy cases
● Secondary
o Distinct cause is identified
▪ Trauma, infection, cerebrovascular disorder
Classification of Epilepsy
34
PHARMACOLOGY NOTES
● Status epilepticus
Antiepileptic Drugs
Mechanism of Action
Antiepileptic Drugs
35
PHARMACOLOGY NOTES
● Long-term therapy with phenytoin may cause gingival hyperplasia, acne, hirsutism, and
Dilantin facies
● Phenobarbital (Solfoton)
o Old drug; VERY long half-life; Used for EVERY seizure; inexpensive
● Primidone
o Metabolized phenobarbital & ?
● Carbamazepine (Tegretol)
o 2nd most common; used for simple-partial
● Valproic Acid
o Used for general & partial seizure
● Phenytoin (Dilantin)
o #1 most commonly used; BLOCKS NA+ channels; Used for tonic & partial
● Fosphenytoin
o Pro-drug (means it’s inactive); used for NPO (nothing by mouth) patients
because it’s easier on the patients veins than phenytoin; metabolized into
phenytoin; done through an IV
36
PHARMACOLOGY NOTES
● Signs and Symptoms include:
o Akinesia
▪ Reduction in or absence of psychomotor activity resulting in mask-like
facial expression and impaired postural reflexes
o Bradykinesia
▪ Slowness of movement
o Rigidity
▪ Resistance to passive movement
o Tremor
▪ Tremor of the thumb against the forefinger, seen mostly at rest and less
severe during voluntary activity; Usually starts one ONE side then
progresses to the other; Is a presenting sign in 70% of cases
o Postural Instability
▪ Unsteadiness that leads to the danger of falling
● A progressive condition
● Rapid swings in response to levodopa occur (Known as the “on-off phenomenon”)
o PD worsens when too little dopamine is present
o Dyskinesia occurs when too much dopamine is present
Dyskinesia
Levodopa Therapy
37
PHARMACOLOGY NOTES
NOT a treatment because things will get progressively worse well on the
levodopa.
● Aimed at increasing the levels of dopamine as long as there are functioning nerve
terminals remaining
● Antagonize or blocks the effects of Ach
● Slows the progression of the disease
● Indirect-acting dopamine-receptor agonists
o MAO-B inhibitors: Selegiline, Rasagiline
▪ Metabolize dopamine and make it last longer
o COMT inhibitors: Entocapone and Tolcapone
▪ Levodopa and dopamine metabolizer; longer half-life
o Presynaptic dopamine release enhancer: Amantadine
▪ Stimulates the release of dopamine presynaptically; ONLY works when
the neurotransmitters are FUNCTIONING
● Anticholinergic Drugs
o Benztropine
o Trihexyphenidyl
● Antihistamines 🡪 Have anticholinergic effects
o Diphenhydramine
● NONdopamine-receptor agonists 🡪 NOT dopamine but STIMULATE dopamine receptors
o Ergot: Bromocriptine
o Nonergot: Pramipexole, Ropinirole, Apomorphine
● Dopamine Replacent Drugs
o Carbidopa, Carbidopa-levodopa
● MOA breaks down the catecholamines in the CNS, primarily in the brain
● Selegiline is a selective MAOB inhibitor
o Causes an increase in levels of dopaminergic stimulation in the CNS
● Selegiline is a newer, potent, and irreversible MAOI that selectively inhibits MAOB
● Does not elicit the “cheese effect” of the nonselective MAOIs used to treat depression (if
10mg or less is used)
● Used in combination with levodopa or carbidopa-levodopa
● Used as an adjunct when a patients response to levodopa is fluctuating
● Allows the dose of levodopa to be DECREASED
o Delays the development of unresponsiveness to levodopa therapy
● Improves function ability
● Decreases severity of signs and symptoms
● Only 50% to 60% of patients show a positive response to therapy
● Prophylactic selegiline may delay the development of serious debilitating PD for 9 to 18
years
38
PHARMACOLOGY NOTES
● Rasagiline approved in 2008 with similar action as selegiline
o Does not work for everyone but this could delay the progression of the disease
● Adverse effects are usually mild
o Nausea, lightheadedness, dizziness, abdominal pain, insomnia, confusion, and
dry mouth
o Doses that are higher than 10 mg per day may cause more serious adverse effects
such as hypertensive crisis
● Amantadine (Symmetrel)
o Indirect-acting
o Causes the release of dopamine from the storage sites at the end of nerve cells
that are still INTACT
o Blocks reuptake of dopamine into the nerve endings, allowing more to
accumulate both centrally and peripherally
o Does not stimulate dopamine receptors directly
▪ Works for about 6-12 months
o Used early in the course of the disease
o Usually effective for only 6-12 months
o Also used as an antiviral for influenza virus infection
COMT Inhibitors
● Indirect-acting
● Tolcapone (Tasmar) 🡪 Longer half-life and can get through the blood-brain barrier
● Entacapone (Comtan)
● Inhibit COMT, the enzyme responsible for the breakdown of the levodopa, the dopamine
precursor
● Prolong the duration of action of levodopa; reduce wearing off phenomenon
● Tolcapone (Tasmar)
o Has caused severe liver failure
o Requires monitoring of liver enzymes
o Not used unless other drugs do not woek
39
PHARMACOLOGY NOTES
▪ Used for PD and restless leg syndrome
o Apomorphine (Apokyn)
▪ Newer, non-ergot dopamine agonist
▪ Subcutaneous injection
o Rotigotine
▪ Transdermal patch
● Direct-acting
o Bromocriptine (Parlodel)
● Directly stimulate dopamine receptors
● Activate dopamine receptors and stimulate production of more dopamine
Anticholinergic Therapy
40
PHARMACOLOGY NOTES
o Also used to treat extrapyramidal symptoms caused by use of antipsychotic drugs
▪ Block dopamine receptors
● Trihexyphenidyl (generic only)
● Antihistamines also have anticholinergic properties
o Diphenhydramine (Benadryl)
41
PHARMACOLOGY NOTES
Biochemical Imbalance
Anxiety
Anxiety Disorders
Psychosis
● Severe emotional disorder that impairs the mental function of the affected individual to
point that the individual cannot participate in activities of daily living
● Hallmark: loss of contact with reality
● Examples:
o Schizophrenia
o Depressive and drug-induced psychoses
Psychotherapeutics: Pathophysiology
42
PHARMACOLOGY NOTES
o Indolamines
▪ Serotonin
▪ Histamine
Antianxiety Drugs
● Anxiety
● Insomnia
● Sedation
● Muscle Spasms
● Seizure Disorder
● Adjuncts in anesthesia
● Adjuvant therapy for depression
● Alcohol (ethanol) withdrawal
Common Benzodiazepines
● Diazepam (Valium)
● Lorazepam (Ativan)
● Alprazolam (Xanax)
● Clonazepam (Klonopin)
● Chlordiazepoxide (Librium)
● Midazolam (Versed)
o Reduces anxiety and patient’s memory of painful procedures that do not require
anesthesia (moderate sedation)
o Injection only
▪ Limited to use as sedative and anesthetic during invasive medical or
surgical procedures
Benzodiazepines
43
PHARMACOLOGY NOTES
o Decreased CNS activity, sedation
o Hypotension
o Drowsiness, loss of coordination, dizziness, headaches
o Nausea, vomiting, dry mouth, constipation
Benzodiazepines: Overdose
● Mood stabilizers
o Used to treat bipolar disorder
▪ Involved cycles of mania, hypomania, and depression
● Antidepressants
o Used to treat depression
Depression
● Etiology
o Biogenic amine hypothesis
▪ Depression and mania are caused by an alteration in neuronal and
synaptic catecholamine concentration at adrenergic receptor sites in the
brain
● Depression: Deficiency of catecholamine, especially
norepinephrine
● Mania: excessive amines
o Permissive hypothesis
▪ Affective disorders are caused by decreased concentration of serotonin
● Depression results from decreases in both serotonin and
catecholamine levels
44
PHARMACOLOGY NOTES
● Mania results from an increased catecholamine level but a
decreased serotonin level
Antidepressants
● Tricyclic antidepressants
● Monoamine oxidase inhibitors (MAOIs)
o Selective serotonin reuptake inhibitors (SSRIs)
o Second and third generation antidepressants
Common Tricyclics
● Amitriptyline (Elavil,Endep)
● Doxepin (Sinequan)
● Imipramine (Tofranil)
● Desipramine (Norpramin)
● Nortriptyline (Aventyl, Pamelor)
Mechanism of Action
Drug Effects
Indications
● Depression
● Childhood enuresis (imipramine)
● Obsessive-compulsive disorders (clomipramine)
● Adjunctive analgesics for chronic pain conditions, such as trigeminal neuralgia
Adverse Effects
● Sedation
● Impotence
45
PHARMACOLOGY NOTES
● Orthostatic hypotension
● Dysrhythmias
● Seizures
● Older patients
o Dizziness, postural hypotension, constipation, delayed micturition, edema,
muscle tremors
Overdose
MAOIs
● Highly effective
● Considered second-line treatment for depression, not responsive to cyclics
● DISADVANTAGE: potential to cause hypertensive crisis when taken with tyramine
● Examples:
o Phenelzine (Nardil)
o Tranylcypromine (Parnate)
MAOIs: Indications
● Ingestion of foods or drinks with tyramine leads to hypertensive crisis, which may lead to
cerebral hemorrhage, stroke, coma, or death
● Avoid foods that contain tyramine !
o Aged, mature cheese (cheddar, blue cheese, and swiss)
o Smoked/pickled or aged meats, fish, poultry
o Yeast extracts
46
PHARMACOLOGY NOTES
o Red wines
o Italian bread beans
MAOIs
Newer-Generation Antidepressants
SSRIs: MoA
Newer-Generation Antidepressants:
● Depression
● Bipolar Disorder
● Obesity
● Eating Disorders
47
PHARMACOLOGY NOTES
● Obsessive-Compulsive Disorder
● Panic attacks or disorders
● Social anxiety disorders
● PTSD
● Treatment of various substance abuse problems (bupropion is used for smoking
cessation treatment)
Serotonin Syndrome
● Signs/symptoms
o Delirium, tachycardia, hyperreflexia, shivering, agitation, sweating, muscle
spasms, coarse tremors
● Signs/symptoms of severe cases
o Hyperthermia, seizures, renal failure, rhabdomyolysis, dysrhythmias,
disseminated intravascular coagulation (DIC)
Antipsychotics
48
PHARMACOLOGY NOTES
● Phenothiazines
● Atypical antipsychotics: new class
Mechanism of Action
● Block dopamine receptors in the brain (limbic system, basal ganglia)- areas associated
with emotion, cognitive function, motor function
● Result: Tranquilizing effect in psychotic patients
● Clozapine (Clozaril)
● Risperidone (Risperdal)
● Olanzapine (Zyprexa)
● Quetiapine (Seroquel)
● Ziprasidone (Geodon)
● Aripiprazole (Abilify)
● Paliperidone (Invega)
Antipsychotics: Indications
Adverse Effects
49
PHARMACOLOGY NOTES
50